GlassScriptPhysician profile
Melissa Ruth Kite
NPI 1811120314
$2,480.53
in general payments reported to CMS, 2019-2025
16 companies · $84.36 in 2025
The $84.36 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,454 · 2024: $942 · 2025: $84.36.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,216 · Education: $265.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,215.56 |
| Education | $264.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $668.52 | 2023-2024 | Tremfya, Simponi, Simponi Aria |
| Lilly USA, LLC | $486.65 | 2023-2024 | Olumiant, Taltz |
| E.R. Squibb & Sons, L.L.C. | $305.25 | 2023-2024 | Sotyktu |
| Regeneron Healthcare Solutions, INC. | $281.51 | 2023-2024 | Dupixent, Libtayo |
| Janssen Scientific Affairs, LLC | $157.97 | 2023-2025 | Tremfya |
| Incyte Corporation | $152.12 | 2023 | Opzelura |
| Ucb, INC. | $117.97 | 2023 | Cimzia, Bimzelx |
| Sanofi-Aventis U.S. LLC | $79.99 | 2024 | |
| Genzyme Corporation | $59.82 | 2023-2024 | |
| Abbvie INC. | $51.75 | 2023-2024 | |
| Dermavant Sciences, INC. | $30.59 | 2024 | Vtama |
| Amgen INC. | $28.25 | 2023 | Otezla |
| Novartis Pharmaceuticals Corporation | $16.43 | 2023 | |
| Arcutis Biotherapeutics, INC. | $15.66 | 2023 | |
| Verrica Pharmaceuticals INC. | $14.15 | 2024 | Ycanth |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $13.90 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Kite listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.